UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
−Removed: There were no unregistered sales of the Company’s equity securities during the quarter ended June 30, 2021 that were not previously reported in a Current Report on Form 8-K except as follows:
−Removed: On August 24, 2020, the Company issued 1,500,000 shares of common stock to a consultant per an agreement entered into on June 25, 2020.
−Removed: On December 25, 2020, the Company renewed the agreement for an additional six months.
−Removed: As consideration for the agreement the Company issued 1,500,000 shares of common stock to the consultant.
+Added: There were no unregistered sales of the Company’s equity securities during the nine months ended December 31, 2021 that were not previously reported in an Annual Report on Form 10-K, a Quarterly Report on Form 10-Q, or a Current Report on Form 8-K except as follows:
+Added: On April 8, 2021, the Company converted 262 Series B into 3,144,000 shares of the Company’s common stock.
+Added: On May 24, 2021, the Company entered into an agreement with a consultant, with a three-month term, that shall automatically renew each three months unless one party terminates the agreement.
+Added: The compensation shall be $12,500 in cash per month for the first six months and $15,000 per month thereafter.
+Added: Also included in compensation are 200,000 shares of common stock, with a fair value of $99,600 based upon the market price of $0.50 upon the grant date.
+Added: The shares of common stock will vest in quarterly installments, with 50,000 to vest immediately, and 50,000 each quarter at $24,900, with $74,700 vested through December 31, 2021.
+Added: During the three months ended December 31, 2021, three consultants were issued a total of approximately 430,000 shares of common stock, with a total fair value of approximately $158,000, based on the market price of $0.36 on the grant date.
+Added: During the three months ended December 31, 2021, a number of new employees were issued a total of 175,000 shares of common stock as signing bonuses, with a total fair value of $68,300, based on the market price of $0.395 on the grant date.
+Added: On December 23, 2021, the Company converted 278 Series B into 3,336,000 shares of the Company’s common stock.
+Added: During the three months ended September 30, 2021, 1,200 shares of Series E Preferred Stock were converted into 4,114,286 shares of common stock.
+Added: During the three months ended December 31, 2021, an additional 1,200 shares of Series E Preferred Stock were converted into 4,114,286 shares of common stock.
The above securities were issued in reliance on the exemption under Section 4(a)(2) of the Securities Act.
9 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.